Local 12, WCPO highlight brain tumor vaccine trial

Local television stations Local 12 and WCPO recently highlighted the Imvax trial that will test a personalized immunotherapy approach designed to work similarly to a vaccine by training the immune system to fight glioblastomas, a deadly brain tumor. 

The University of Cincinnati is a study site for the new Phase 2b clinical trial, and Soma Sengupta, MD, PhD, is the site principal investigator.

In the trial, glioblastoma patients will have their tumors removed, and then their tumor cells will be combined with a novel drug to create a personalized vaccine. The combination is then inserted into the patients' abdomens, allowing the immune system to train to fight the tumor cells.

"The patient is making their own antibodies, and their own immune system is working to try and beat this cancer," Sengupta told Local 12.

Watch the Local 12 story.

Read the WCPO story.

Read more about the trial.

Featured photo at top of glioblastoma cells in culture courtesy of National Cancer Institute.

Related Stories

8360 Results
1

Cincinnati researchers want to know if MRIs can work better

June 28, 2024

WVXU and the Cincinnati Business Courier highlighted a new collaboration between the University of Cincinnati College of Medicine, UC Health GE HealthCare, JobsOhio, REDI Cincinnati and Cincinnati Children’s to create an MRI Research and Development Center of Excellence located on UC’s medical campus.

2

UC opens Blood Cancer Healing Center

June 28, 2024

Media outlets including WLWT, Local 12, Spectrum News, the Cincinnati Enquirer and Cleveland.com highlighted the opening of the University of Cincinnati Cancer Center's Blood Cancer Healing Center.

4

Free Wi-Fi, work area coming to Greater Cincinnati

June 27, 2024

St. Lawrence Park in Price Hill now has free Wi-Fi and a furnished outdoor space for community members to access digital needs. The space is part of The Nodes Project, which stands for “Neighborhoods of Design Engagement": a collaboration between UC DAAP communication designers and community entities.